SELLAS Life Sciences
SLS
SLS
34 hedge funds and large institutions have $4.57M invested in SELLAS Life Sciences in 2017 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
70% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 23
Holders
34
Holding in Top 10
–
Calls
$1.26M
Puts
$84K
Top Buyers
| 1 | +$361K | |
| 2 | +$113K | |
| 3 | +$104K | |
| 4 |
ECM
Element Capital Management
New York
|
+$93K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$70K |
Top Sellers
| 1 | -$316K | |
| 2 | -$114K | |
| 3 | -$84.2K | |
| 4 |
SG Americas Securities
New York
|
-$77K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$54K |